These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1025 related items for PubMed ID: 26009802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q, Wang Y, Bian L, Xu M, Liang Z.
    Emerg Microbes Infect; 2016 Jul 20; 5(7):e75. PubMed ID: 27436364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY, Liu CC.
    Expert Rev Vaccines; 2018 Sep 20; 17(9):819-831. PubMed ID: 30095317
    [Abstract] [Full Text] [Related]

  • 5. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC, Guo MS, Wu SR, Lin HY, Yang YT, Liu WC, Chow YH, Shieh DB, Wang JR, Chong P.
    Antiviral Res; 2016 May 20; 129():58-66. PubMed ID: 26899790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Hoa-Tran TN, Dao ATH, Nguyen AT, Kataoka C, Takemura T, Pham CH, Vu HM, Hong TTT, Ha NTV, Duong TN, Thanh NTH, Shimizu H.
    Vaccine; 2020 Dec 14; 38(52):8273-8285. PubMed ID: 33223308
    [Abstract] [Full Text] [Related]

  • 11. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H, Zhang Z, Rao Q, Wang X, Wang M, Du T, Tang J, Long S, Zhang J, Luo J, Pan Y, Chen J, Ma J, Liu X, Fan M, Zhang T, Sun Q.
    Emerg Microbes Infect; 2021 Dec 14; 10(1):619-628. PubMed ID: 33682641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
    Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, Gao F, Wu X, Ye Q, Xu M, Li XL, Zhu FC, Liang ZL.
    J Med Virol; 2015 Dec 14; 87(12):2009-17. PubMed ID: 26010334
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X, Zhang C, Wang X, Ren X, Peng H, Tang X, Zhang L, Chen Z, Ye Y, Zheng M, Zhong W, Chen X, Zeng Y, Yuan P, Long L.
    Emerg Microbes Infect; 2022 Dec 14; 11(1):2510-2519. PubMed ID: 36103331
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.